elunonavir   Click here for help

GtoPdb Ligand ID: 11667

Compound class: Synthetic organic
Comment: The chemical structure for elunonavir was obtained from WHO Proposed list 125. The IUPAC>SMILES conversion maps to PubChem CID 135301900. Via SureChEMBL we can trace this compound to a Gilead Sciences patent that claims antiviral compounds for the treatment of HIV [1]. From the patent it would appear that elunonavir is an HIV protease inhibitor.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 18
Hydrogen bond donors 5
Rotatable bonds 27
Topological polar surface area 217.64
Molecular weight 1155.44
XLogP 8.47
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC(=O)N[C@@H](C(C(F)(F)F)(C)C)C(=O)N[C@H]([C@H](CN(Cc1c(F)cc(cc1F)c1ccn(n1)C(F)F)NC(=O)[C@H](C(C(F)(F)F)(C)C)NC(=O)OC)O)Cc1ccc(cc1)C#Cc1cnc(nc1)N1CC2CCC(C1)N2C1COC1
Isomeric SMILES CC(C)([C@@H](C(=O)N[C@@H](Cc1ccc(cc1)C#Cc1cnc(nc1)N1CC2CCC(C1)N2C1COC1)[C@H](CN(Cc1c(cc(cc1F)c1nn(cc1)C(F)F)F)NC(=O)[C@H](C(C)(C)C(F)(F)F)NC(=O)OC)O)NC(=O)OC)C(F)(F)F
InChI InChI=1S/C52H59F10N11O8/c1-49(2,51(57,58)59)41(66-47(77)79-5)43(75)65-39(17-29-10-7-28(8-11-29)9-12-30-20-63-46(64-21-30)70-22-32-13-14-33(23-70)73(32)34-26-81-27-34)40(74)25-71(69-44(76)42(67-48(78)80-6)50(3,4)52(60,61)62)24-35-36(53)18-31(19-37(35)54)38-15-16-72(68-38)45(55)56/h7-8,10-11,15-16,18-21,32-34,39-42,45,74H,13-14,17,22-27H2,1-6H3,(H,65,75)(H,66,77)(H,67,78)(H,69,76)/t32?,33?,39-,40-,41+,42+/m0/s1
InChI Key ZTSLYWLHCOINNI-FTEFBJIISA-N
References
1. Bacon EM, Chin E, Cottell JJ, Katana AA, Kato D, Link JO, Shapiro N, Martin TAT, Yang Z-Y. (2020)
HIV inhibitor compounds.
Patent number: US10752636B2. Assignee: Gilead Sciences Inc. Priority date: 06/02/2017. Publication date: 25/08/2020.